2 completed, 1 recruiting, 1 terminated, 1 unknown. 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow XTR004: new trials by email Literature Review of XTR004 trials Research Report on XTR004
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR) XTR004 - Coronary Artery Disease(CAD) | Phase 3 | Recruiting | Sinotau Pharmaceutical Group | 395 | 2025-11-14 | 2026-03-03 |
| Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis XTR004 - Myocardial Perfusion Imaging, Diagnostic Certainty | Phase 2 | Terminated | Sinotau Pharmaceutical Group | 17 | 2024-12-19 | 2026-01-12 |
| Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD XTR004 - Coronary Artery Disease (CAD) | Phase 2 | Completed | Sinotau Pharmaceutical Group | 83 | 2022-02-15 | 2023-06-02 |
| A Study of XTR004 Radiotracer in Healthy Volunteers XTR004 - Coronary Artery Disease (CAD), Myocardial Ischemia | Phase 1 | Completed | Sinotau Pharmaceutical Group | 10 | 2021-03-23 | 2022-02-07 |
| 18F-FMPP PET MPI in the Detection of Coronary Artery Disease 18F-FMPP - Coronary Disease | Early Phase 1 | Unknown | Peking Union Medical College Hospital | 100 | 2020-09-15 | 2020-10-23 |
Coronary Artery Disease (3) · Coronary Disease (1) · Myocardial Ischemia (1)
Sinotau Pharmaceutical Group (4) · Peking Union Medical College Hospital (1)
China (5)
Li Huo, PhD (1)